Cardiome Pharma Corp. appointed Justin Renz as Chief Financial Officer. Jennifer Archibald, the current CFO will be appointed as Chief Business Operations Officer.

David Dean, Cardiome's VP Business Development and Investor Relations, has been appointed to the position of Chief Business Development Officer, Hugues Sachot, Cardiome's SVP Commercial, has been appointed to the position of Chief Commercial Officer. Mr. Renz recently served as Executive Vice President, Chief Financial Officer and Treasurer at Karyopharm Therapeutics.